Company Filing History:
1 out of 23 
1 out of 83 
Years Active: 2012
Title: Bettina Hinkelmann: Innovator in Cancer Treatment
Introduction
Bettina Hinkelmann is a prominent inventor based in Braunschweig, Germany. She has made significant contributions to the field of medical research, particularly in the treatment of proliferative diseases such as cancer. Her innovative work has led to the development of a unique patent that addresses critical health challenges.
Latest Patents
Bettina Hinkelmann holds a patent for the "Use of inhibitors of the degradation of p27, in particular Argyrin and derivatives thereof, for the treatment of proliferative diseases." This invention focuses on the use of specific macrocycles that inhibit the proteasomic degradation of p27, with a particular emphasis on Argyrin A and its derivatives. The implications of this patent are profound, as it offers potential therapeutic avenues for treating various forms of cancer.
Career Highlights
Throughout her career, Bettina has worked with esteemed institutions, including the Helmholtz Centre for Infection Research and the Hannover Medical School. Her dedication to advancing medical science has positioned her as a key figure in her field.
Collaborations
Bettina has collaborated with notable colleagues such as Nisar Malek and Florenz Sasse, contributing to a rich exchange of ideas and research advancements.
Conclusion
Bettina Hinkelmann's innovative work in cancer treatment exemplifies the impact of dedicated research and invention in the medical field. Her contributions continue to inspire future advancements in healthcare.